Interaction between inflammation-related gene polymorphisms and cigarette smoking on the risk of myocardial infarction in the Physician's Health Study

Human Genetics

Volumn 118, Issue 2, 2005, Pages 287-294

  Rosner, Sarah A ^a,b   Ridker, Paul M ^b   Zee, Robert Y L ^b   Cook, Nancy R ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Epidemiology; Gene environment interaction; Inflammation; Myocardial infartion; Polymorphism; Smoking

Indexed keywords

ARGININE; ASPARAGINE; EOTAXIN; GLYCINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; INTERLEUKIN 6; ISOLEUCINE; LEUCINE; PADGEM PROTEIN; PROLINE; SERINE; THREONINE; VALINE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; CASE CONTROL STUDY; CIGARETTE SMOKING; CONTROLLED STUDY; DOMINANT INHERITANCE; GENETIC POLYMORPHISM; GENOTYPE ENVIRONMENT INTERACTION; HEART INFARCTION; HUMAN; INFLAMMATION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK FACTOR; WILD TYPE;

AMINO ACID SUBSTITUTION; CASE-CONTROL STUDIES; CHEMOKINES, CC; COHORT STUDIES; CYTOKINES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; ODDS RATIO; P-SELECTIN; PHYSICIANS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-4; RISK FACTORS; SELENOPROTEIN P; SMOKING; VASCULAR CELL ADHESION MOLECULE-1;

EID: 27944432628     PISSN: 03406717     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00439-005-0052-6     Document Type: Article

References (32)

1. Barbaux SC, Blankenberg S, Rupprecht HJ, Francomme C, Bickel C, Hafner G, Nicaud V, Meyer J, Cambien F, Tiret L (2001) Association between P-selectin gene polymorphisms and soluble P-selectin levels and their relation to coronary artery disease. Arterioscler Thromb Vasc Biol 21:1668-1673 11597943
2. Basso F, Lowe GD, Rumley A, McMahon AD, Humphries SE (2002) Interleukin-6 -174G>C polymorphism and risk of coronary heart disease in West of Scotland coronary prevention study (WOSCOPS). Arterioscler Thromb Vasc Biol 22:599-604 10.1161/01.ATV.0000013283.84306.1A
3. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 57:289-300
4. Bermudez EA, Rifai N, Buring JE, Manson JE, Ridker PM (2002) Relation between markers of systemic vascular inflammation and smoking in women. Am J Cardiol 89:1117-1119 10.1016/S0002-9149(02)02284-1
5. Byron K, Varigos G, Wootton A (1994) Il-4 production is increased in cigarette smokers. Clin Exp Immunol 95:333-336 8306509
6. Carter AM, Anagnostopoulou K, Mansfield MW, Grant PJ (2003) Soluble p-selectin levels, p-selectin polymorphisms and cardiovascular disease. J Thromb Haemost 1:1718-1723 10.1046/j.1538-7836.2003.00312.x
7. Devlin B, Risch N (1995) A comparison of linkage disequilibrium measures for fine-scale mapping. Genomics 29:311-322 10.1006/geno.1995.9003
8. Dong ZM, Chapman SM, Brown AA, Frenette PS, Hynes RO, Wagner DD (1998) The combined role of P- and E-selectins in atherosclerosis. J Clin Invest 102:145-52 9649568
9. Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, Arveiler D, Tiret L, Cambien F (2001) New polymorphisms in the interleukin-10 gene-relationships to myocardial infarction. Eur J Clin Invest 31:9-14 10.1046/j.1365-2362.2001.00754.x
10. Georges JL, Loukaci V, Poirier O, Evans A, Luc G, Arveiler D, Ruidavets JB, Cambien F, Tiret L (2001) Interleukin-6 gene polymorphisms and susceptibility to myocardial infarction: The ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde J Mol Med 79:300-5
11. Hackstein H, Heckler M, Kruse S, Bohnert A, Ober C, Deichmann K, Bein G (2001) A novel polymorphism in the 5′ promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 53:264-269 10.1007/s002510100324
12. Haley KJ, Lilly CM, Yang JH, Feng Y, Kennedy SP, Turi TG, Thompson JF, Sukhova GH, Libby P, Lee RT (2000) Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: Using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102: 2185-2189 11056090
13. Heeschen C, Dimmeler S, Hamm CW, Fichtlscherer S, Boersma E, Simoons ML, Zeiher AM, Investigators CS (2003) Serum level of the antiinflammatory cytokine interleukin-10 is an important prognostic determinant in patients with acute coronary syndromes. Circulation 107:2109-2114 10.1161/01.CIR.0000065232.57371.25
14. Herrmann SM, Ricard S, Nicaud V, Mallet C, Evans A, Ruidavets JB, Arveiler D, Luc G, Cambien F (1998) The P-selectin gene is highly polymorphic: Reduced frequency of the Pro715 allele carriers in patients with myocardial infarction. Hum Mol Genet 7:1277-1284 10.1093/hmg/ 7.8.1277
15. Hershey GKK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The Association of Atopy with a Gain-of-Function Mutation in the alpha Subunit of the Interleukin-4 Receptor. N Engl J Med 337:1720-1725 10.1056/NEJM199712113372403
16. Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ (2001) The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22:2243-2252 10.1053/euhj.2001.2678
17. Hwang S, Ballantyne C, AR S (1997) Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study. Circulation 96:4219-4225 9416885
18. Jenny NS, Tracy RP, Ogg MS, Luong Le A, Kuller LH, Arnold AM, Sharrett AR, Humphries SE (2002) In the elderly, interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22:2066-2071 10.1161/01.ATV.0000040224.49362.60
19. Kovanen P, Manttari M, Palosuo T, Mannienen V, Aho K (1998) Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch of Intern Med 158:1434-1439 10.1001/archinte.158.13.1434
20. Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135-1143 10.1161/hc0902.104353
21. de Maat MP, Kluft C (2002) The association between inflammation markers, coronary artery disease and smoking. Vas Pharmacol 39:137-139 10.1016/ S1537-1891(02)00301-4
22. Mitsuyasu H, Izuhara K, Mao X, Gao P, Arinobu Y, Enomoto T, Kawai M, Sasaki S, Dake Y, Hamasaki N, Shirakawa T, Hopkin J (1998) Ile50val variant of IL4Ralpha upregulates IgE synthesis and associates with atopic asthma. Nat Genet 19:119-120 10.1038/472
23. Nauck M, Winkelmann BR, Hoffmann MM, Bohm BO, Wieland H, Marz W (2002) The interleukin-6 G(-174)C promoter polymorphism in the LURIC cohort: No association with plasma interleukin-6, coronary artery disease, and myocardial infarction. J Mol Med 80: 507-513 10.1007/s00109-002-0354-2
24. Niiro H, Otsuka T, Izuhara K, Yamaoka K, Ohshima K, Tanabe T, Hara S, Nemoto Y, Tanaka Y, Nakashima H, Niho Y (1997) Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 89: 1621-1628 9057644
25. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998) Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88-92 10.1016/S0140-6736(97)09032-6
26. Ridker P, Rifai N, Stampfer M, Hennekens C (2000) Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767-1772 10769275
27. Ridker P, Buring J, Rifai N (2001) Soluble P-selectin and the risk of future cardiovascular events. Circulation 103:491-495 11157711
28. Wallenstein S, Hodge S, Weston A (1998) Logistic regression model for analyzing extended haplotype data. Genet Epidemiol 15:173-181 10.1002/ (SICI)1098-2272(1998)15:2<173::AID-GEPI5>3.0.CO;2-7
29. Wang XL, Raveendran M, Wang J (2003) Genetic influence on cigarette-induced cardiovascular disease. Progr Cardiovas Dis 45:361-382
30. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V (2000) Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis. 148:209-214 10.1016/S0021-9150(99)00463-3
31. Zee R, Cook N, Cheng S, Erlich H, Lindpaintner K, Lee R, Ridker P (2004a) Threonine for alanine substitution in the eotaxin (CCL11) gene and the risk of incident myocardial infarction. Atherosclerosis 175:91-94 10.1016/j.atherosclerosis.2004.01.042
32. Zee RYL, Cook NR, Cheng S, Reynolds R, Erlich HA, Lindpaintner K, Ridker PM (2004b) Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: A population-based, prospective genetic analysis. Hum Mol Genet 13:389-396 10.1093/hmg/ddh039